GSK plc (GSK) Q1 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-04-29 15:01:59 ET
GSK plc (GSK) Q1 2026 Earnings Call April 29, 2026 7:00 AM EDT
Company Participants
Luke Miels - CEO & Director
Nina Mojas - President of Global Product Strategy
Deborah Waterhouse - CEO of ViiV Healthcare & President of Global Health
Tony Wood - Chief Scientific Officer and Head of R&D
Julie Brown - CFO & Executive Director
...
Read the full article on Seeking Alpha
For further details see:
GSK plc (GSK) Q1 2026 Earnings Call Transcript
GSK plc American Depositary Shares (Each representing two)
NASDAQ: GSK
GSK Trading
1.21% G/L:
$52.37 Last:
2,698,925 Volume:
$51.91 Open:
GSK Latest News
March 13, 2026 11:44:00 am
GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
February 23, 2026 01:13:00 pm
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
GSK Stock Data
$120,291,791,432
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
